Clinical trial
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
NCT02535871 is registered in ClinicalTrials.gov with Valeant Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
- Lead sponsor
- Valeant Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- September 30, 2015
- Completion date
- July 31, 2016
- Enrollment
- 800 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.